Latest Tweets:
"As the continuing financial doldrums temper the appetite of traditional private equity venture capital (VC) for startups, investment funds set up by big pharma companies are beginning to dominate early-stage financing of biotech firms."
Nature Biotechnology 27, 403 - 404 (2009). Corporate venture funds chase early-stage deals, Peter Mitchell
